Jim Simons Processa Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.18 - $0.84 $774 - $3,612	4,300 Added 7.98%	58,200 $19,000
Q3 2023 Nov 14, 2023	BUY	$0.24 - $0.53 $2,040 - $4,505	8,500 Added 18.72%	53,900 $13,000
Q2 2023 Aug 11, 2023	BUY	$0.44 - $0.73 $6,248 - $10,366	14,200 Added 45.51%	45,400 $23,000
Q1 2023 May 12, 2023	BUY	$0.41 - $1.3 $7,011 - $22,230	17,100 Added 121.28%	31,200 $16,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $50.0 $2,640 - $120,000	2,400 Added 20.51%	14,100 $16,000
Q3 2022 Nov 14, 2022	BUY	$2.0 - $46.8 $200 - $4,680	100 Added 0.86%	11,700 $26,000
Q2 2022 Aug 12, 2022	BUY	$1.68 - $3.55 $19,488 - $41,180	11,600 New	11,600 $33,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.